double heterozygotes
exon duplication
genetic counseling
hereditary breast and ovarian cancer syndrome (HBOC)
multi-gene panel testing
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Jun 2024
06 Jun 2024
Historique:
received:
17
04
2024
revised:
29
05
2024
accepted:
30
05
2024
medline:
19
6
2024
pubmed:
19
6
2024
entrez:
19
6
2024
Statut:
epublish
Résumé
For patients with hereditary breast and ovarian cancer, the probability of carrying two pathogenic variants (PVs) in dominant cancer-predisposing genes is rare. Using targeted next-generation sequencing (NGS), we investigated a 49-year-old Caucasian woman who developed a highly aggressive breast tumor. Our analyses identified an intragenic germline heterozygous duplication in
Identifiants
pubmed: 38892462
pii: ijms25116274
doi: 10.3390/ijms25116274
pii:
doi:
Substances chimiques
Tumor Suppressor Protein p53
0
BRCA1 Protein
0
TP53 protein, human
0
BRCA1 protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM